Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.4749
Delayed Data
As of Jun 24
 -0.0338 / -6.64%
Today’s Change
0.39
Today|||52-Week Range
6.44
-83.90%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close0.51
Today’s open0.47
Day’s range0.46 - 0.50
Volume7,217,290
Average volume (3 months)4,099,890
Market cap$29.9M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+41.01%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...-0.00-3.75%
OGXIOncoGenex Pharmaceut...-0.09-8.82%
ITUSITUS Corp-0.18-5.39%
SCYXSCYNEXIS Inc+0.01+0.46%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

Partner Offers

Search for Jobs